Artificial intelligence has the potential to transform how life sciences companies engage with patients, physicians, and the broader healthcare ecosystem. But while the promise is real, so are the ...

In today's digitally driven world, data has become the lifeblood of the healthcare and life sciences industry. From genomic sequencing data to real world patient records, data drives decision-making ...

Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single ...